News

FDA Approves RizaFilm® (rizatriptan) Oral Film for the Treatment of Acute Migraine

April 17, 2023

Read More »

FDA Commissioner and Chief Scientist Announce Decision to Withdraw Approval of Makena

April 6, 2023

Read More »

Gohibic

April 4, 2023

Read More »

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension, USP 750mg/5mL Due to Potential Bacillus Cereus Contamination in the Product

March 31, 2023

Read More »

FDA Approves First Over-the-Counter Naloxone Nasal Spray

March 29, 2023

Read More »

Newly Approved Indications

March 29, 2023

Read More »

Joenja®

March 24, 2023

Read More »

Rezzayo

March 22, 2023

Read More »

Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

March 22, 2023

Read More »

Benefit Advisors & Employees - Want to know more?

Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager

Full Name(Required)

Email(Required)

Comment(Required)

Company Name(Required)

CAPTCHA